UTHealth Houston Study on Repeated Radiofrequency Ablation in Combination with Chemotherapy for Pancreatic Cancer Supported with $3.3M HHS Grant
University of Texas Health Science Center at HoustonA combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.